Journal of Clinical InvestigationGenomicsPeer-reviewed journal article
HIV-1 Viremia Not Suppressible By Antiretroviral Therapy Can Originate from Large T-Cell Clones Producing Infectious Virus
Elias Konstantine HalvasiD, Kevin W. JosephiD, Leah D. BrandtiD, Shuang GuoiD, Michele D. Sobolewski, Jana L. JacobsiD, Camille TumiottoiD, John K. BuiiD, Joshua C. CyktoriD, Brandon F. KeeleiD, Gene D. MorseiD, Michael J. BaleiD, Wei ShaoiD, Mary F. KearneyiD, John M. CoffiniD, Jason W. RauschiD, Xiaolin WuiD, Stephen H. HughesiD, John W. MellorsiD
Abstract
BACKGROUNDHIV-1 viremia that is not suppressed by combination antiretroviral therapy (ART) is generally attributed to incomplete medication adherence and/or drug resistance. We evaluated individuals referred for non-suppressible viremia (plasma HIV-1 RNA above 40 copies/ml) who reported adherence to ART and did not show drug resistance to their current regimen. METHODSSamples were collected from at least two time points from eight donors who had non-suppressible viremia for more than six months on ART. Single templates of HIV-1 RNA obtained from plasma and viral outgrowth of cultured cells and from proviral DNA were PCR-amplified and sequenced for evidence of clones of cells that produced infectious viruses. Clones were identified by host-proviral integration site analysis. RESULTSHIV-1 genomic RNAs with identical sequences were identified in plasma samples from all eight donors. The identical viral RNA sequences did not change over time and lacked resistance to the ART regimen. In four of the donors, viral RNA sequences obtained from plasma matched those sequences from viral outgrowth cultures, indicating that the viruses were replication-competent. Integration sites for infectious proviruses from those four donors were mapped to introns of the MATR3, ZNF268, ZNF721/ABCA11P, and ABCA11P genes. The sizes of the clones were from 50 million to 350 million cells. CONCLUSIONClones of HIV-1-infected cells producing virus can cause failure of ART to suppress viremia despite medication adherence and absence of drug resistance. The mechanisms involved in clonal expansion and persistence need to be defined to eliminate viremia and the HIV-1 reservoir.
- Citations
- 141
- FWCI
- 10.01
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption
B. Cole, L. Lambrechts, … L. Vandekerckhove·bioRxiv·Feb 4, 2021
- Prolonged non-suppressible viremia sustained by a clonally expanded, genomically defective provirus with an immune-evasive HIV protein expression profile
F. Harrison Omondi, Yurou Sang, … Zabrina L. Brumme·mBioPeer-reviewed·Mar 30, 2026
- Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia
Fengting Wu, Milica Moskovljevic, … Francesco Roberto Simonetti·Science Translational MedicinePeer-reviewed·Aug 13, 2025
- A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage
Matthew Moeser, Nathan Long, … Sarah Joseph·The Journal of Infectious DiseasesPeer-reviewed·Apr 16, 2026
- HIV-1 envelopes from virions that persist in plasma on antiretroviral therapy show reduced susceptibility to autologous immunoglobulins and variable sensitivity to broadly neutralizing monoclonal antibodies
Savrina Manhas, Joseph P. Brooker, … Elias Konstantine Halvas·bioRxiv·May 22, 2025
- In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia
B. Cole, L. Lambrechts, … L. Vandekerckhove·bioRxiv·Feb 15, 2021